ZOLBEN ZOLBEN PROCONE RABOSH RABOSH REPAR REPAR BEPRA BEPRA REBAZ REBAZ PROMTO PROMTO RABECID RABECID RPZ RPZ PROTORIB PROTORIB BEBRA ACIPHEXA RABETEC RAPRO RABEZOLE BEZOLID RAPEZOL RATISER RATISER ZECHIN REVOLT REVOLT REPIT REPIT ARZOL ARZOL ISRA ARRO ARRO RABZ RABZ STAREB RABIXIN RABZOLE RABZOLE RABEK REBEK REBZER REBZER AWAPRO NOVIPRAZ NOVIPRAZ Rabeloc RABECAP ACIFIX ALCIFIX VIROTAB VIROTAB RABEP EC RABITON RABITON RABIPRA RABIPRA APT APT ALBIZOLE ALBIZOLE WIBER WIBER CARARIB CARARIB CARA-RIB CARA-RIB RABEADVAN ROBETEC RABEZIN REBELOC R-ZOLE R-ZOLE RENOM REBIP REBIP RIBAZEP RIBAZEP REBOSIVE REBOSIVE BROMASAL RANSID PRAZOLE

Dose: 20 mg
Single Dose: 20 (20)
Frequency: 24 hourly
Route: PO
Instructions: For 4-8 weeks.

Rabeprazole (Na) is the derivative of Rabeprazole. It is of Synthetic origin and belongs to Sulphinyl Benzimidazole. . The Molecular Weight of Rabeprazole is 359.40.

Rabeprazole is contraindicated in conditions like Hypersensitivity to the drug.

The symptomatic adverse reactions produced by Rabeprazole are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Diarrhea, Nervousness, Abdominal pain, Pharyngitis, Weight gain, Cough, Asthenia, Influenza like syndrome, Rhinitis, Chest pain, UTI, Sinusitis.

Rabeprazole is primarily indicated in conditions like Gastro-esophageal reflux disease, Peptic ulcer.

No data regarding the interactions of Rabeprazole was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Proton pump inhibitors (e.g Rabeprazole) should be given with caution in patients with renal impairment, liver disease, in pregnancy and in breast-feeding. Proton-pump inhibitors may mask symptoms of gastric cancer, particular care is required in those whose symptoms change and in those over 45 years of age; the presence of gastric malignancy should be excluded before treatment.